应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
GRCE GRACE THERAPEUTICS INC
休市中 07-25 16:00:00 EDT
3.08
-0.12
-3.75%
盘后
3.08
+0.00
0.00%
16:23 EDT
最高
3.19
最低
3.05
成交量
6.78万
今开
3.15
昨收
3.20
日振幅
4.22%
总市值
4,259万
流通市值
2,376万
总股本
1,383万
成交额
21.01万
换手率
0.88%
流通股本
771.42万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Grace Therapeutics, Inc.2025财年实现净利润-9.57百万美元,同比增加25.53%
市场透视 · 06-24
Grace Therapeutics, Inc.2025财年实现净利润-9.57百万美元,同比增加25.53%
Grace Therapeutics(GRCE.US):2025年Q4财报实现营收0美元;每股收益为0.10美元,预期值
智通财经 · 06-23
Grace Therapeutics(GRCE.US):2025年Q4财报实现营收0美元;每股收益为0.10美元,预期值
Grace Therapeutics第三季度每股收益为-0.36美元, 低于预估的-0.34美元
财报速递 · 02-13
Grace Therapeutics第三季度每股收益为-0.36美元, 低于预估的-0.34美元
Grace Therapeutics, Inc.2024财年第三财季实现净利润-3.43百万美元,同比减少4.89%
市场透视 · 2024-11-22
Grace Therapeutics, Inc.2024财年第三财季实现净利润-3.43百万美元,同比减少4.89%
加载更多
公司概况
公司名称:
GRACE THERAPEUTICS INC
所属市场:
NASDAQ
上市日期:
--
主营业务:
Grace Therapeutics, Inc.成立于2002年2月1日。他们专注于开发和商业化用于罕见和孤儿疾病的产品,这些产品有可能通过使用他们的新型药物递送技术来改善临床结果。他们寻求将新的专有配方应用于已获批准和上市的药物化合物,以实现增强疗效、更快起效、减少副作用、更方便的药物递送和提高患者依从性。
发行价格:
--
{"stockData":{"symbol":"GRCE","market":"US","secType":"STK","nameCN":"GRACE THERAPEUTICS INC","latestPrice":3.08,"timestamp":1753473600000,"preClose":3.2,"halted":0,"volume":67847,"hourTrading":{"tag":"盘后","latestPrice":3.08,"preClose":3.08,"latestTime":"16:23 EDT","volume":10,"amount":30.8,"timestamp":1753475002369},"delay":0,"floatShares":7714224,"shares":13828562,"eps":-0.791576,"marketStatus":"休市中","change":-0.12,"latestTime":"07-25 16:00:00 EDT","open":3.15,"high":3.185,"low":3.05,"amount":210134.81925,"amplitude":0.042188,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.791576,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1753689600000},"marketStatusCode":7,"adr":0,"listingDate":1357534800000,"exchange":"NASDAQ","adjPreClose":3.2,"postHourTrading":{"tag":"盘后","latestPrice":3.08,"preClose":3.08,"latestTime":"16:23 EDT","volume":10,"amount":30.8,"timestamp":1753475002369},"volumeRatio":1.0721035310762046},"requestUrl":"/m/hq/s/GRCE","defaultTab":"news","newsList":[{"id":"2546237975","title":"Grace Therapeutics, Inc.2025财年实现净利润-9.57百万美元,同比增加25.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546237975","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546237975?lang=zh_cn&edition=full","pubTime":"2025-06-25 02:00","pubTimestamp":1750788007,"startTime":"0","endTime":"0","summary":"6月25日,Grace Therapeutics, Inc.公布财报,公告显示公司2025财年净利润为-9.57百万美元,同比增加25.53%;其中营业收入为0.00美元,每股基本收益为-0.79美元。机构评级:截至2025年6月25日,当前有2家机构对Grace Therapeutics, Inc.目标价做出预测,其中目标均价为11.50美元,其中最低目标价为11.00美元,最高目标价为12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625020018a4bbe6a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625020018a4bbe6a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","GRCE"],"gpt_icon":0},{"id":"2545262410","title":"Grace Therapeutics(GRCE.US):2025年Q4财报实现营收0美元;每股收益为0.10美元,预期值","url":"https://stock-news.laohu8.com/highlight/detail?id=2545262410","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545262410?lang=zh_cn&edition=full","pubTime":"2025-06-23 22:01","pubTimestamp":1750687291,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4007","BK4539","GRCE","BK4139","LENZ"],"gpt_icon":0},{"id":"1108073478","title":"Grace Therapeutics第三季度每股收益为-0.36美元, 低于预估的-0.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1108073478","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108073478?lang=zh_cn&edition=full","pubTime":"2025-02-13 21:09","pubTimestamp":1739452160,"startTime":"0","endTime":"0","summary":"Grace Therapeutics第三季度每股收益为-0.36美元, 低于预估的-0.34美元以上内容来自Benzinga Earnings专栏,原文如下:Grace $Therapeutics(LENZ)$ Q3 EPS $(0.36) Vs $(0.34) Estimate","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","GRCE"],"gpt_icon":0},{"id":"2485982672","title":"Grace Therapeutics, Inc.2024财年第三财季实现净利润-3.43百万美元,同比减少4.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485982672","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485982672?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:00","pubTimestamp":1732291227,"startTime":"0","endTime":"0","summary":"11月23日,Grace Therapeutics, Inc.公布财报,公告显示公司2024财年第三财季净利润为-3.43百万美元,同比减少4.89%;其中营业收入为0.00美元,每股基本收益为-0.30美元。从资产负债表来看,Grace Therapeutics, Inc.总负债9.22百万美元,其中短期债务0.00美元,资产负债比为7.09,流动比率为6.02。机构评级:截至2024年11月23日,当前有3家机构对Grace Therapeutics, Inc.目标价做出预测,其中目标均价为10.83美元,其中最低目标价为8.00美元,最高目标价为12.50美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000055a24e4853&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000055a24e4853&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","GRCE"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gracetx.com","stockEarnings":[{"period":"1week","weight":-0.0833},{"period":"1month","weight":0.0405},{"period":"3month","weight":0.2369},{"period":"6month","weight":-0.2103},{"period":"1year","weight":0.0883},{"period":"ytd","weight":-0.1765}],"compareEarnings":[{"period":"1week","weight":0.0152},{"period":"1month","weight":0.0494},{"period":"3month","weight":0.157},{"period":"6month","weight":0.0479},{"period":"1year","weight":0.1833},{"period":"ytd","weight":0.0871}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Grace Therapeutics, Inc.成立于2002年2月1日。他们专注于开发和商业化用于罕见和孤儿疾病的产品,这些产品有可能通过使用他们的新型药物递送技术来改善临床结果。他们寻求将新的专有配方应用于已获批准和上市的药物化合物,以实现增强疗效、更快起效、减少副作用、更方便的药物递送和提高患者依从性。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.035531},{"month":2,"riseRate":0.307692,"avgChangeRate":-0.033972},{"month":3,"riseRate":0.384615,"avgChangeRate":-0.056637},{"month":4,"riseRate":0.230769,"avgChangeRate":-0.036832},{"month":5,"riseRate":0.615385,"avgChangeRate":-0.001291},{"month":6,"riseRate":0.538462,"avgChangeRate":0.01107},{"month":7,"riseRate":0.538462,"avgChangeRate":0.153239},{"month":8,"riseRate":0,"avgChangeRate":-0.174241},{"month":9,"riseRate":0.5,"avgChangeRate":0.089843},{"month":10,"riseRate":0.083333,"avgChangeRate":-0.133596},{"month":11,"riseRate":0.5,"avgChangeRate":-0.027308},{"month":12,"riseRate":0.75,"avgChangeRate":0.07041}],"exchange":"NASDAQ","name":"GRACE THERAPEUTICS INC","nameEN":"GRACE THERAPEUTICS INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GRACE THERAPEUTICS INC(GRCE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供GRACE THERAPEUTICS INC(GRCE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"GRACE THERAPEUTICS INC,GRCE,GRACE THERAPEUTICS INC股票,GRACE THERAPEUTICS INC股票老虎,GRACE THERAPEUTICS INC股票老虎国际,GRACE THERAPEUTICS INC行情,GRACE THERAPEUTICS INC股票行情,GRACE THERAPEUTICS INC股价,GRACE THERAPEUTICS INC股市,GRACE THERAPEUTICS INC股票价格,GRACE THERAPEUTICS INC股票交易,GRACE THERAPEUTICS INC股票购买,GRACE THERAPEUTICS INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GRACE THERAPEUTICS INC(GRCE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供GRACE THERAPEUTICS INC(GRCE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}